HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Saadettin Kılıçkap Selected Research

Inflammation (Inflammations)

12/2022The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study.
10/2022The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Saadettin Kılıçkap Research Topics

Disease

9Neoplasms (Cancer)
07/2023 - 01/2020
5Neoplasm Metastasis (Metastasis)
01/2023 - 06/2019
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2023 - 01/2022
3Adenocarcinoma
08/2023 - 10/2021
3Carcinoma (Carcinomatosis)
03/2022 - 08/2021
2Breast Neoplasms (Breast Cancer)
02/2024 - 12/2022
2Neuroendocrine Tumors (Neuroendocrine Tumor)
10/2023 - 01/2020
2Colorectal Neoplasms (Colorectal Cancer)
12/2022 - 06/2019
2Inflammation (Inflammations)
12/2022 - 10/2022
2Renal Cell Carcinoma (Grawitz Tumor)
12/2022 - 12/2021
2Kidney Neoplasms (Kidney Cancer)
12/2022 - 12/2021
2Stomach Neoplasms (Stomach Cancer)
06/2022 - 10/2021
2Urinary Bladder Neoplasms (Bladder Cancer)
03/2022 - 08/2021
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2023
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2022
1Male Breast Neoplasms (Male Breast Cancer)
12/2022
1Lung Neoplasms (Lung Cancer)
08/2022
1Disease Progression
06/2022
1Prostatic Neoplasms (Prostate Cancer)
05/2021
1Cholangiocarcinoma
02/2021
1medullary Thyroid cancer
09/2020
1Pulmonary Fibrosis (Fibrosing Alveolitis)
07/2020
1Fibrosis (Cirrhosis)
07/2020
1COVID-19
01/2020

Drug/Important Bio-Agent (IBA)

4atezolizumabIBA
12/2022 - 08/2021
3PlatinumIBA
03/2022 - 08/2021
2Hormones (Hormone)IBA
02/2024 - 12/2022
2ErbB Receptors (EGF Receptor)IBA
02/2024 - 12/2022
2CrizotinibIBA
07/2023 - 08/2022
2alectinibIBA
07/2023 - 01/2022
2NivolumabIBA
12/2022 - 12/2021
2Trastuzumab (Herceptin)FDA Link
06/2022 - 10/2021
2Hemoglobins (Hemoglobin)IBA
03/2022 - 08/2021
1palbociclibIBA
02/2024
1ribociclibIBA
02/2024
1Cyclin-Dependent Kinases (cdk Proteins)IBA
02/2024
1Anaplastic Lymphoma KinaseIBA
11/2023
1Capecitabine (Xeloda)FDA Link
10/2023
1Temozolomide (Temodar)FDA LinkGeneric
10/2023
1Biomarkers (Surrogate Marker)IBA
12/2022
1Proton Pump InhibitorsIBA
12/2022
1Cyclin-Dependent Kinase 4IBA
12/2022
1regorafenibIBA
12/2022
1Phosphotransferases (Kinase)IBA
10/2022
1entrectinibIBA
08/2022
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
08/2022
1Cisplatin (Platino)FDA LinkGeneric
06/2022
1Tyrosine Kinase InhibitorsIBA
01/2022
1taxaneIBA
10/2021
1CreatinineIBA
08/2021
1gallium Ga 68 dotatateIBA
09/2020
1EverolimusFDA Link
07/2020
1Sirolimus (Rapamycin)FDA Link
07/2020
1OMS 2017IBA
01/2020
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2020
1Yttrium-90IBA
06/2019

Therapy/Procedure

8Drug Therapy (Chemotherapy)
12/2022 - 07/2020
7Therapeutics
01/2023 - 07/2020
2Immunotherapy
03/2022 - 08/2021
2Microspheres (Microsphere)
02/2021 - 06/2019
1Metastasectomy
08/2023
1Radiotherapy
07/2020